✦ LIBER ✦

Meta-analysis of individual participant data: rationale, conduct, and reporting

✍ Scribed by Riley, R. D. ;Lambert, P. C. ;Abo-Zaid, G.

Book ID: 111865310
Publisher: BMJ Publishing Group
Year: 2010
Tongue: English
Weight: 601 KB
Volume: 340
Category: Article
ISSN: 0959-8138
DOI: 10.1136/bmj.c221

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Meta-analysis of a binary outcome using

Meta-analysis of a binary outcome using individual participant data and aggregate data

✍ Richard D. Riley; Ewout W. Steyerberg 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 213 KB

## Abstract In this paper, we develop meta‐analysis models that synthesize a binary outcome from health‐care studies while accounting for participant‐level covariates. In particular, we show how to synthesize the observed event‐risk across studies while accounting for the within‐study association b

How systematic reviews and meta-analyses

How systematic reviews and meta-analyses based on individual participant data can inform trial design and conduct

✍ Jayne Tierney,Claire Vale,Jean-Pierre Pignon,Francois Gueffyier,Lisa Askie… 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 121 KB

Individual participant data meta-analysi

Individual participant data meta-analysis of prognostic factor studies:state of the art?

✍ Ghada Abo-Zaid, Willi Sauerbrei, Richard D Riley 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 500 KB

Combining individual participant and agg

Combining individual participant and aggregated data in a meta-analysis with correlational studies

✍ Terri Pigott; Ryan Williams; Joshua Polanin 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 157 KB

Developing and validating risk predictio

Developing and validating risk prediction models in an individual participant data meta-analysis

✍ Ahmed, Ikhlaaq; Debray, Thomas PA; Moons, Karel GM; Riley, Richard D 📂 Article 📅 2014 🏛 BioMed Central 🌐 English ⚖ 332 KB

Meta-analysis using individual participa

Meta-analysis using individual participant data is the gold standard for diagnostic studies

✍ Ming-Hua Zheng; Ke-Qing Shi; Yu-Chen Fan; Yong-Ping Chen 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 632 KB

Shorter duration and lower dose of peginterferon alfa-2a therapy results in inferior HBeAg seroconversion rates compared with the duration and dose of 48 weeks and 180 lg: NEPTUNE study.